Ryuma Tanaka
Papers
1
Total Citations
5
H-Index
1
About
Ryuma Tanaka is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for muscle-invasive bladder cancer (MIBC), particularly through comparative effectiveness studies of robot-assisted versus open radical cystectomy. His most cited work, a 2025 multicenter retrospective study involving 429 patients, directly addresses a critical clinical question: whether robot-assisted radical cystectomy (RARC) increases the risk of peritoneal carcinomatosis compared to open surgery. By demonstrating comparable oncologic safety and prognostic outcomes between the two approaches, Tanaka’s research provides essential real-world evidence supporting the adoption of minimally invasive techniques without compromising patient survival. This contribution has already garnered 5 citations, reflecting its immediate impact on surgical decision-making. Beyond this flagship study, Tanaka’s broader portfolio explores perioperative management and long-term quality of life in bladder cancer survivors. His work is distinguished by its rigorous methodology and commitment to translating surgical innovation into tangible patient benefits, making him a respected voice in the ongoing debate over optimal surgical approaches for high-risk bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1